Posted On: 11/05/2014 1:05:45 PM
Post# of 94305
$JNJ Recent Headlines
Republican victory will boost these 21 stocks 7:45 a.m. Today - Michael Brush
Ebola play Halyard Health stock gains are modest 1:02 p.m. Nov. 3, 2014 - Russ Britt
Ebola-nation travelers to U.S. to be watched 21 days 3:04 p.m. Oct. 22, 2014 - Russ Britt
Johnson & Johnson to begin testing Ebola vaccine in January 9:14 a.m. Oct. 22, 2014 - Jonathan D. Rockoff
A possible new Ebola vaccine from Johnson&Johnson 4:32 a.m. Oct. 22, 2014 - MarketWatch
Fighting Ebola though investing: one firm’s approach 6:42 p.m. Oct. 21, 2014 - Wallace Witkowski
3 stocks Ken Fisher likes 11:09 a.m. Oct. 21, 2014 - Insider Monkey
Updates, advisories and surprises 5:31 p.m. Oct. 14, 2014 - MarketWatch
Delta, Citigroup gain; J.P. Morgan, Wells Fargo slide following results 10:58 a.m. Oct. 14, 2014 - Sue Chang
Newscast: Google launches same-day delivery 9:58 a.m. Oct. 14, 2014 - MarketWatch
All the reasons to sell this market are enough to draw a guy in 9:23 a.m. Oct. 14, 2014 - Shawn Langlois
J&J's earnings jump on higher drug sales 8:12 a.m. Oct. 14, 2014 - MarketWatch.com
Johnson & Johnson shares gain after profit beat, raised outlook 7:59 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson shares up 1% premarket after Q3 results 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson ups 2014 EPS outlook to $5.92-$5.97 from $5.85-$5.92 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 net EPS $1.66 vs. $1.04 a year ago 7:49 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales of $18.5 bln vs. FactSet consensus $18.44 bln 7:48 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales up 5.1% from last year to $18.5 bln 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 adj. EPS $1.50 vs. FactSet consensus $1.45 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore
What to expect from Johnson & Johnson’s earnings 7:09 a.m. Oct. 14, 2014 - Tomi Kilgore
Pharmacyclics Tops Q3 Earnings, Ties Up with AstraZeneca - Analyst Blog 12:00 p.m. Today - Zacks.com
Biosimilars: The Good, the Bad and the Unknown 10:36 a.m. Today - Barrons.com
Tracking Yacktman Asset Management Portfolio - Q3 2014 Update 6:56 a.m. Today - Seeking Alpha
Elliott Gears Up for Proxy Fight With IPG 7:53 p.m. Nov. 4, 2014 - The Wall Street Journal Interactive Edition
Dividend Growth Stocks With A Defined Benefit Pension 7:34 p.m. Nov. 4, 2014 - Seeking Alpha
The 4 DJIA Stocks Leading the Market to a Mixed Close 3:43 p.m. Nov. 4, 2014 - 247WallSt.com
3 Stocks Raising The Drugs Industry Higher 2:13 p.m. Nov. 4, 2014 - TheStreet.com
Dividend Growth Stocks With A Defined-Benefit Pension 10:26 a.m. Nov. 4, 2014 - GuruFocus.com
AstraZeneca teams up with Pharmacyclics and Janssen in cancer combo 9:28 a.m. Nov. 4, 2014 - Seeking Alpha
Stock Picks For This Year 9:36 p.m. Nov. 3, 2014 - Seeking Alpha
Bracing For Both Bull And Bear 7:58 p.m. Nov. 3, 2014 - Seeking Alpha
Gilead's EPS Miss Is Investors' Gain: Gilead's A Buy On Harvoni Success 8:49 a.m. Nov. 3, 2014 - Seeking Alpha
Why Did Gilead Drop Friday? Is It Justified Or Just An Overreaction? 8:41 a.m. Nov. 3, 2014 - Seeking Alpha
Retirement Strategy: ETF Only Portfolio Vs. Buy The Dips Portfolio - The Results Are Crystal Clear 12:01 a.m. Nov. 3, 2014 - Seeking Alpha
Retirement Strategy: Yes Folks, We Really Did Have A Correction, Honestly 7:24 p.m. Nov. 2, 2014 - Seeking Alpha
American Century manager picks 5 stocks for the next market downturn 8:25 a.m. Nov. 1, 2014 - Seeking Alpha
GlaxoSmithKline: Why I Bought Shares Of This High-Yield Health Care Stock 5:00 p.m. Oct. 31, 2014 - Seeking Alpha
Stock Market News for October 31, 2014 - Market News 10:10 a.m. Oct. 31, 2014 - Zacks.com
Retirees Feeling Anxious? Take 3 Of These Pharmaceuticals, Then Call Me In The Morning 9:00 p.m. Oct. 30, 2014 - Seeking Alpha
Protecting Your Portfolio And Selling For Capital Gains: Is It Worth It For Dividend Growth Investors? 7:53 p.m. Oct. 30, 2014 - Seeking Alpha
DECN's Subsidiary Initiates First in Industry Social Media Marketing Campaign for Genstrip50 9:26 a.m. Today - ACCESSWIRE
Baron and Budd Investigating Potential Xarelto Lawsuits 4:03 p.m. Nov. 4, 2014 - BusinessWire - BZX
Legal-Bay Lawsuit Settlement Funding Updates News on All Major Hip Litigations 5:00 a.m. Nov. 4, 2014 - PR Newswire - PRF
Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019 8:00 p.m. Oct. 30, 2014 - PR Newswire - PRF
In 2023, Medivation/Astellas Pharma's Xtandi Will Be the Top-Selling Agent in the Prostate Cancer Market Across the United States, Europe, and Japan 1:00 p.m. Oct. 30, 2014 - PR Newswire - PRF
Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire 9:15 a.m. Oct. 30, 2014 - PR Newswire - PRF
Johnson & Johnson Diabetes Solutions Companies Join The Joslin Institute for Technology Translation (JITT) As Founding Members 9:00 a.m. Oct. 30, 2014 - BusinessWire - BZX
Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson & Johnson Development Corporation 5:15 a.m. Oct. 29, 2014 - Thomson Reuters ONE
Johnson & Johnson Innovation Launches Asia Pacific Innovation Center and Announces New Alliances 4:00 p.m. Oct. 28, 2014 - PR Newswire - PRF
GTCR Announces Sale of Devicor Medical Products 7:32 a.m. Oct. 28, 2014 - BusinessWire - BZX
Global and China Monoclonal Antibody Industry Report, 2014-2019 9:26 p.m. Oct. 27, 2014 - PR Newswire - PRF
Axxess Pharma Retains Natural Products Consulting Institute "NPCI" for Health Canada Approval of TapouT High Potency Omega-3 Fish Oil and TapouT Turbo Blend Protein Powder 8:02 a.m. Oct. 23, 2014 - Marketwired
Bavarian Nordic Announces Expanded Collaboration with Janssen on MVA-BN(R) for Additional Infectious Disease Targets 5:47 p.m. Oct. 22, 2014 - Thomson Reuters ONE
TransPerfect Princeton Opens for Business 9:45 a.m. Oct. 22, 2014 - BusinessWire - BZX
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine 2:06 a.m. Oct. 22, 2014 - GlobeNewswire
Johnson & Johnson Announces Major Commitment to Speed Ebola Vaccine Development and Significantly Expand Production 2:02 a.m. Oct. 22, 2014 - PR Newswire - PRF
Bavarian Nordic Announces Additional Details Concerning the Issue of Shares to Johnson & Johnson Development Corporation 1:56 a.m. Oct. 22, 2014 - Thomson Reuters ONE
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine 1:56 a.m. Oct. 22, 2014 - Thomson Reuters ONE
Vaccines, Medical Oxygen, and Helping the Ebola Crisis 1:47 p.m. Oct. 21, 2014 - ACCESSWIRE
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Republican victory will boost these 21 stocks 7:45 a.m. Today - Michael Brush
Ebola play Halyard Health stock gains are modest 1:02 p.m. Nov. 3, 2014 - Russ Britt
Ebola-nation travelers to U.S. to be watched 21 days 3:04 p.m. Oct. 22, 2014 - Russ Britt
Johnson & Johnson to begin testing Ebola vaccine in January 9:14 a.m. Oct. 22, 2014 - Jonathan D. Rockoff
A possible new Ebola vaccine from Johnson&Johnson 4:32 a.m. Oct. 22, 2014 - MarketWatch
Fighting Ebola though investing: one firm’s approach 6:42 p.m. Oct. 21, 2014 - Wallace Witkowski
3 stocks Ken Fisher likes 11:09 a.m. Oct. 21, 2014 - Insider Monkey
Updates, advisories and surprises 5:31 p.m. Oct. 14, 2014 - MarketWatch
Delta, Citigroup gain; J.P. Morgan, Wells Fargo slide following results 10:58 a.m. Oct. 14, 2014 - Sue Chang
Newscast: Google launches same-day delivery 9:58 a.m. Oct. 14, 2014 - MarketWatch
All the reasons to sell this market are enough to draw a guy in 9:23 a.m. Oct. 14, 2014 - Shawn Langlois
J&J's earnings jump on higher drug sales 8:12 a.m. Oct. 14, 2014 - MarketWatch.com
Johnson & Johnson shares gain after profit beat, raised outlook 7:59 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson shares up 1% premarket after Q3 results 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson ups 2014 EPS outlook to $5.92-$5.97 from $5.85-$5.92 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 net EPS $1.66 vs. $1.04 a year ago 7:49 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales of $18.5 bln vs. FactSet consensus $18.44 bln 7:48 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales up 5.1% from last year to $18.5 bln 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 adj. EPS $1.50 vs. FactSet consensus $1.45 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore
What to expect from Johnson & Johnson’s earnings 7:09 a.m. Oct. 14, 2014 - Tomi Kilgore
Pharmacyclics Tops Q3 Earnings, Ties Up with AstraZeneca - Analyst Blog 12:00 p.m. Today - Zacks.com
Biosimilars: The Good, the Bad and the Unknown 10:36 a.m. Today - Barrons.com
Tracking Yacktman Asset Management Portfolio - Q3 2014 Update 6:56 a.m. Today - Seeking Alpha
Elliott Gears Up for Proxy Fight With IPG 7:53 p.m. Nov. 4, 2014 - The Wall Street Journal Interactive Edition
Dividend Growth Stocks With A Defined Benefit Pension 7:34 p.m. Nov. 4, 2014 - Seeking Alpha
The 4 DJIA Stocks Leading the Market to a Mixed Close 3:43 p.m. Nov. 4, 2014 - 247WallSt.com
3 Stocks Raising The Drugs Industry Higher 2:13 p.m. Nov. 4, 2014 - TheStreet.com
Dividend Growth Stocks With A Defined-Benefit Pension 10:26 a.m. Nov. 4, 2014 - GuruFocus.com
AstraZeneca teams up with Pharmacyclics and Janssen in cancer combo 9:28 a.m. Nov. 4, 2014 - Seeking Alpha
Stock Picks For This Year 9:36 p.m. Nov. 3, 2014 - Seeking Alpha
Bracing For Both Bull And Bear 7:58 p.m. Nov. 3, 2014 - Seeking Alpha
Gilead's EPS Miss Is Investors' Gain: Gilead's A Buy On Harvoni Success 8:49 a.m. Nov. 3, 2014 - Seeking Alpha
Why Did Gilead Drop Friday? Is It Justified Or Just An Overreaction? 8:41 a.m. Nov. 3, 2014 - Seeking Alpha
Retirement Strategy: ETF Only Portfolio Vs. Buy The Dips Portfolio - The Results Are Crystal Clear 12:01 a.m. Nov. 3, 2014 - Seeking Alpha
Retirement Strategy: Yes Folks, We Really Did Have A Correction, Honestly 7:24 p.m. Nov. 2, 2014 - Seeking Alpha
American Century manager picks 5 stocks for the next market downturn 8:25 a.m. Nov. 1, 2014 - Seeking Alpha
GlaxoSmithKline: Why I Bought Shares Of This High-Yield Health Care Stock 5:00 p.m. Oct. 31, 2014 - Seeking Alpha
Stock Market News for October 31, 2014 - Market News 10:10 a.m. Oct. 31, 2014 - Zacks.com
Retirees Feeling Anxious? Take 3 Of These Pharmaceuticals, Then Call Me In The Morning 9:00 p.m. Oct. 30, 2014 - Seeking Alpha
Protecting Your Portfolio And Selling For Capital Gains: Is It Worth It For Dividend Growth Investors? 7:53 p.m. Oct. 30, 2014 - Seeking Alpha
DECN's Subsidiary Initiates First in Industry Social Media Marketing Campaign for Genstrip50 9:26 a.m. Today - ACCESSWIRE
Baron and Budd Investigating Potential Xarelto Lawsuits 4:03 p.m. Nov. 4, 2014 - BusinessWire - BZX
Legal-Bay Lawsuit Settlement Funding Updates News on All Major Hip Litigations 5:00 a.m. Nov. 4, 2014 - PR Newswire - PRF
Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019 8:00 p.m. Oct. 30, 2014 - PR Newswire - PRF
In 2023, Medivation/Astellas Pharma's Xtandi Will Be the Top-Selling Agent in the Prostate Cancer Market Across the United States, Europe, and Japan 1:00 p.m. Oct. 30, 2014 - PR Newswire - PRF
Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire 9:15 a.m. Oct. 30, 2014 - PR Newswire - PRF
Johnson & Johnson Diabetes Solutions Companies Join The Joslin Institute for Technology Translation (JITT) As Founding Members 9:00 a.m. Oct. 30, 2014 - BusinessWire - BZX
Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson & Johnson Development Corporation 5:15 a.m. Oct. 29, 2014 - Thomson Reuters ONE
Johnson & Johnson Innovation Launches Asia Pacific Innovation Center and Announces New Alliances 4:00 p.m. Oct. 28, 2014 - PR Newswire - PRF
GTCR Announces Sale of Devicor Medical Products 7:32 a.m. Oct. 28, 2014 - BusinessWire - BZX
Global and China Monoclonal Antibody Industry Report, 2014-2019 9:26 p.m. Oct. 27, 2014 - PR Newswire - PRF
Axxess Pharma Retains Natural Products Consulting Institute "NPCI" for Health Canada Approval of TapouT High Potency Omega-3 Fish Oil and TapouT Turbo Blend Protein Powder 8:02 a.m. Oct. 23, 2014 - Marketwired
Bavarian Nordic Announces Expanded Collaboration with Janssen on MVA-BN(R) for Additional Infectious Disease Targets 5:47 p.m. Oct. 22, 2014 - Thomson Reuters ONE
TransPerfect Princeton Opens for Business 9:45 a.m. Oct. 22, 2014 - BusinessWire - BZX
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine 2:06 a.m. Oct. 22, 2014 - GlobeNewswire
Johnson & Johnson Announces Major Commitment to Speed Ebola Vaccine Development and Significantly Expand Production 2:02 a.m. Oct. 22, 2014 - PR Newswire - PRF
Bavarian Nordic Announces Additional Details Concerning the Issue of Shares to Johnson & Johnson Development Corporation 1:56 a.m. Oct. 22, 2014 - Thomson Reuters ONE
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine 1:56 a.m. Oct. 22, 2014 - Thomson Reuters ONE
Vaccines, Medical Oxygen, and Helping the Ebola Crisis 1:47 p.m. Oct. 21, 2014 - ACCESSWIRE
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
(0)
(0)
